07.23.18
Rentschler Fill Solutions GmbH, a CMO and expert for aseptic fill and finish services, announced the appointment of Dr. Margit Klotz as general manager, Operations, effective August 1, 2018.
In this newly created position, Dr. Klotz will be in charge of Process Development & Manufacturing, Quality and Engineering. She joins the company from German Rentschler Biopharma SE, where she held positions of increasing responsibility over the last ten years, most recently as vice president, managing the Aseptic Filling unit. Dr. Klotz provides more than twenty years of experience in aseptic filling in international biotechnology and pharmaceutical companies. She studied chemistry in Ulm, Germany, and obtained her PhD in molecular genetics.
Prof. Dr. Nikolaus F. Rentschler. said, “Dr. Klotz combines her extensive experience in the filling of biopharmaceuticals and her long-standing affiliation with Rentschler Biopharma with an extraordinary degree of technical expertise and quality awareness. For us and our customers, this puts her in an ideal position at the interface between drug substance manufacturing at Rentschler Biopharma and drug product fill and finish at Rentschler Fill Solutions, in line with our corporate philosophy.”
In this newly created position, Dr. Klotz will be in charge of Process Development & Manufacturing, Quality and Engineering. She joins the company from German Rentschler Biopharma SE, where she held positions of increasing responsibility over the last ten years, most recently as vice president, managing the Aseptic Filling unit. Dr. Klotz provides more than twenty years of experience in aseptic filling in international biotechnology and pharmaceutical companies. She studied chemistry in Ulm, Germany, and obtained her PhD in molecular genetics.
Prof. Dr. Nikolaus F. Rentschler. said, “Dr. Klotz combines her extensive experience in the filling of biopharmaceuticals and her long-standing affiliation with Rentschler Biopharma with an extraordinary degree of technical expertise and quality awareness. For us and our customers, this puts her in an ideal position at the interface between drug substance manufacturing at Rentschler Biopharma and drug product fill and finish at Rentschler Fill Solutions, in line with our corporate philosophy.”